Sexually Transmitted Diseases (STD) Testing Market
Sexually transmitted diseases testing market accounted for $91,445.93 Million in 2020, and is expected to reach $1,50,445.01 Million by 2030, registering a CAGR of 5.1% from 2021 to 2030. The STD market growth is strongly driven by high incidence rates and increase in prevalence rates of STDs such as chlamydia, syphilis, and gonorrhea. Moreover, implementation of national screening programs to improve and increase the STD diagnosis in many key geographies such as U.S., UK, Canada, and support in reimbursement for STDs testing are further supporting the sexually transmitted diseases (STD) testing market growth. However, there is social stigma associated with patients visiting specialized STD clinics which refrain patients from STD diagnosis. Moreover, huge proportion of patients infected with STDs are based in out-of-reach geographic areas which significantly limits the diagnosis of STDs. Such factors are expected to restrain the STD testing market growth.
๐๐ข๐ฌ๐ญ ๐จ๐ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ :
This report provides comprehensive competitive analysis and profiles of prominent market players such as Abbott laboratories, Becton Dickinson Company, BioMรฉrieux, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Diasorin Molecular LLC, Hologic, Inc., Orasure Technologies, Inc., Roche Holding AG and Thermo Fisher Scientific Inc.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ https://www.alliedmarketresearch.com/request-sample/1775
At present, STDs are considered as one of the most critical health challenges globally. Chlamydia, gonorrhea, and herpes simplex virus are some of the highly prevalent STDs. The STD testing market has gained prominence in the recent years due to high prevalence of major STDs worldwide and as a result, increase in need for STD diagnosis. However, limited access to STD diagnosis in majority of the population from developing regions is expected to restrain the sexually transmitted diseases (STD) testing market growth.
๐๐ฎ๐ฒ ๐๐จ๐ฐ https://www.alliedmarketresearch.com/checkout-final/05bcbac4d4a881389b9c9b2d37497e69
By disease type, the chlamydia testing segment is the highest revenue contributor and gonorrhea segment is expected to exhibit the fastest growth rate of 7.3%. This is attributed to the increased prevalence of gonorrhea in the last decade.
๐ ๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ https://www.alliedmarketresearch.com/purchase-enquiry/1775
๐๐๐ ๐ ๐๐๐๐๐๐๐ ๐๐ ๐๐๐ ๐๐๐๐๐
By intubation, the orotracheal intubation segment held the largest sexually transmitted diseases (STD) testing market share in 2020 and is expected to remain dominant during the forecast period.
By application, the anesthesia segment held the largest market share in 2020 and is expected to remain dominant during the forecast period.
By end user, the hospitals segment held the largest sexually transmitted diseases testing market share in 2020 and is expected to remain dominant during the forecast period.
๐๐ฎ๐ซ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง ๐๐ซ๐จ๐ฏ๐ข๐๐๐ฌ ๐๐จ๐ฎ ๐๐ง๐ฌ๐ฐ๐๐ซ ๐ญ๐จ ๐๐๐ฅ๐จ๐ฐ ๐๐๐ง๐ญ๐ข๐จ๐ง๐๐ ๐๐ฎ๐๐ฌ๐ญ๐ข๐จ๐ง:
โข Which are the driving factors responsible for the growth of market?
โข Which are the roadblock factors of this market?
โข What are the new opportunities, by which market will grow in coming years?
โข What are the trends of this market?
โข Which are main factors responsible for new product launch?
โข How big is the global & regional market in terms of revenue, sales and production?
โข How far will the market grow in forecast period in terms of revenue, sales and production?
โข Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
โข How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
โข Which region has more opportunities?
Contact:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
[email protected]
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
This release was published on openPR.
Discovered on: 2023-02-27 06:36:18
Source: Sexually Transmitted Diseases (STD) Testing Market Expected